This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Reversing Skin Cellular Aging Is Now Possible As Demonstrated In A Study At Texas A&M University

SAN DIEGO, Dec. 12, 2012 /PRNewswire/ -- Thursday, December 13 th, 2012 at 6:00 pm at Venetian Resort Hotel & Casino Exhibition Hall Booth # 2062 – International Press Conference with Dr. Ron Shane, the Chief Investigator on Research which shows how the SCRx® Products has reversed cellular aging in mouse skin cells, when utilization in a systemic manner – Refreshments will be served.

Millennia Concepts Biotech, LLC in conjunction with Texas A&M Institute for Genomic Medicine has sponsored a breakthrough study which demonstrates that systemic injections into mice once a week over a 90 day period has changed the gene expression in older mice where they become more similar to a younger phenotype.  Most importantly, the proprietary formula of the topical SCRx® product when injected systemically into mice causes up and down regulate thousands of genes where they become similar to younger animals.   

In general, treated mice showed a more youthful robustness or overall gene expression profile compared to older untreated mice.  This is now the only topical skin agent available which has been shown truly to impact thousands of different genes in the rodent model.  Thus, this serum is the first topical substance to actually affect gene and protein expression in a manner characteristic of a younger animal.  The active molecular dynamics of the SCRx® product has demonstrated in ameliorative capacity to reverse aging in mice. In addition, Dr. Ron Shane, Chief Investigator of the landmark study will be presenting his findings at 1:00 pm Saturday, December 15, 2012 at Veronese Ball Room – Venetian Resort Hotel & Casino at the 20th Annual World Congress On Anti-Aging And Regenerative Medicine to doctors involved with this aspect of clinical medicine.

SOURCE Millennia Concepts Biotech, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.01 -1.30%
FB $117.56 -0.42%
GOOG $704.65 1.30%
TSLA $210.29 -5.50%
YHOO $37.01 2.80%


Chart of I:DJI
DOW 17,638.52 -22.19 -0.13%
S&P 500 2,042.95 -7.68 -0.37%
NASDAQ 4,695.9680 -21.1260 -0.45%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs